Related Experiment Videos
Immunodominance does not result from peptide competition for MHC class II presentation
R Lo-Man1, J P Langeveld, P Martineau
1Unité de Biologie des Régulations Immunitaires, Institut Pasteur, Paris, France. rloman@pasteur.fr
Journal of Immunology (Baltimore, Md. : 1950)
|February 20, 1998
Summary
Peptide competition for MHC binding is not the main driver of immunodominance. Studies show that altering competitor peptides or deleting epitopes in MalE protein did not affect T cell responses, challenging existing theories.
Area of Science:
- Immunology
- Molecular Biology
Background:
- Antigen presentation by APCs involves competition for MHC class II binding.
- Limited peptide presentation by APCs is crucial for immune responses.
Purpose of the Study:
- To investigate the role of peptide competition in MHC class II binding and immunodominance.
- To determine if competition influences T cell epitope presentation from the MalE protein.
Main Methods:
- Identified six immunodominant T cell determinants in the MalE protein in DBA/1 (I-Aq) mice.
- Assessed binding affinity of MalE peptides to I-Aq molecules using competition assays with a hepatitis B surface antigen peptide.
- In vivo experiments involved using competitor peptides and deleting MalE epitopes to assess T cell proliferation.
Main Results:
- MalE peptides showed varying binding capacities (weak, intermediate, strong) to I-Aq molecules.
- In vitro, weak and intermediate binders' T cell responses were inhibited by a competitor peptide, but strong binders were not.
- In vivo, inserting a competitor peptide into MalE or deleting epitopes did not alter T cell proliferation responses to other determinants.
Conclusions:
- Peptide competition for MHC class II binding may not be the primary factor determining immunodominance.
- T cell epitope processing and presentation are complex and not solely dictated by competitive binding affinities.